“It Won’t Be China That Takes Control — It’ll Be Musk”: Enrique Abeyta Says Trump’s AI Order Hands Elon the Reins of America’s Machine Future

“It Won't Be China That Takes Control — It'll Be Musk”: Enrique Abeyta Says Trump's AI Order Hands Elon the Reins of America's Machine Future GlobeNewswire June 02, 2025 WASHINGTON, June 01, 2025 (GLOBE NEWSWIRE) — Most headlines worry about foreign AI dominance. But former hedge fund manager Enrique Abeyta sees a different threat rising […]

TransNusa Increases Scheduled Flight Frequency to Twice Daily

South East Asia's first holistic premium service airline, PT TransNusa Aviation Mandiri, is further strengthening its presence in Perth by increasing the frequency of its scheduled flights for its Bali – Perth route to twice daily or 14 times a week from its current 7 times a week. TransNusa Group Chief Executive Officer, Datuk Bernard

Crypto Lottery’s Biggest Unclaimed Win: $211,992 Search Underway for Player ‘Supah Man’

LOLCasino.io urges mystery winner “Supah Man” to claim the $211,992 crypto lotto prize believed to be the largest unclaimed win of its kind to date. Image by LOLCasino NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) — A $211,992.86 prize from a verified Eurojackpot crypto lottery bet on LOLCasino.io remains unclaimed, sparking a public search for

Crypto Lottery’s Biggest Unclaimed Win: $211,992 Search Underway for Player ‘Supah Man’

Crypto Lottery's Biggest Unclaimed Win: $211,992 Search Underway for Player 'Supah Man' GlobeNewswire June 02, 2025 LOLCasino.io urges mystery winner “Supah Man” to claim the $211,992 crypto lotto prize believed to be the largest unclaimed win of its kind to date. Image by LOLCasino NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) — A $211,992.86 prize

VIATRIS 48 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against Viatris Inc. – VTRS

NEW YORK, NY AND NEW ORLEANS, LA / ACCESS Newswire / June 1, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 3, 2025 to file lead plaintiff applications in a securities class action lawsuit against

Peacock 1953 Aircraft Hand Watch: Heritage Meets Horological Innovation in a Tribute to China’s Watchmaking Pioneers

PeacockWatch today launches the Peacock Perfection Classic 1953 “Aircraft Hand”, a limited-edition timepiece that marries mid-century Chinese watchmaking heritage with 21st-century craftsmanship. Inspired by the original “Aircraft Hand” of the 1970s Hongqi (Red Flag) commemorative watch produced by Liaoning Watch Factory, this model revives a symbol of national pride and technological triumph with modern refinement

CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of the pivotal Phase II clinical trial in China (CT041-ST-01, NCT04581473) investigating satricabtagene autoleucel (“satri-cel”, CT041) (a Claudin18.2-specific autologous CAR T-cell product candidate) in patients with Claudin18.2-positive, advanced gastric/gastroesophageal junction cancer refractory to at least

Toronto’s Top Creators

TORONTO, June 01, 2025 (GLOBE NEWSWIRE) — The Toronto Star's Culture section is a showcase of unique people who make our world more interesting, inclusive and inspiring and once each year the editorial team puts a celebratory focus on the city's Top Creators. On the weekend, the Star dropped its annual special feature with its

Toronto’s Top Creators

Toronto's Top Creators Toronto Star's annual influencer spotlight features 10 GTA content creators and an engaging platform for sponsors GlobeNewswire June 02, 2025 TORONTO, June 01, 2025 (GLOBE NEWSWIRE) — The Toronto Star's Culture section is a showcase of unique people who make our world more interesting, inclusive and inspiring and once each year the

2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2a-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, announces that the clinical data of IBI363 (first-in-class PD-1/IL-2a-biasbispecific antibody fusion protein) monotherapy and combo-therapy with bevacizumab in advanced colorectal cancer were orally presented

Scroll to Top